• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Robert Schmad

    Robert Schmad

    Robert Schmad is an investigative reporter at the Washington Examiner.

    How Big Pharma’s web of interests groups pushes its agenda across the country
    Investigations

    How Big Pharma’s web of interests groups pushes its agenda across the country

    Robert Schmad -
    May 13, 2025 12:43 pm
    0
    Chinese President Xi Jinping, right, invites winners of the national medals to join him after a ceremony held in the Great Hall of the People in Beijing, Sunday, Sept. 29, 2024.
    Investigations

    Liberal philanthropies tap Chinese industry to fill endowments

    Robert Schmad -
    May 12, 2025 1:07 pm
    0
    Microsoft President and Chief Legal Officer Brad Smith, accompanied by Attorney Josh Rosenkranz, left, speaks to reporters outside the Supreme Court in Washington. The Supreme Court heard arguments Tuesday in a dispute between the Trump administration and Microsoft Corp. over a warrant for emails that were sought as part of a drug trafficking investigation.
    News

    Democrats invite Microsoft to advise Congress on CCP AI race despite its pro-China history

    Robert Schmad -
    May 8, 2025 11:09 am
    0
    It is no different than [the question of] should anybody ever have been able to tell the phone company to get information, should anybody be able to get at bank records,
    Investigations

    Bill Gates’s charity deeply invested in Chinese military companies

    Robert Schmad -
    May 7, 2025 2:46 pm
    0
    Musk and major banks entangled with Chinese battery manufacturer under scrutiny from feds
    Investigations

    Musk and major banks entangled with Chinese battery manufacturer under scrutiny from feds

    Robert Schmad -
    May 7, 2025 10:50 am
    0
    Democratic presidential candidates, former New York City Mayor Mike Bloomberg, left, and former Vice President Joe Biden talk during a break in a Democratic presidential primary debate hosted by NBC News and MSNBC, Wednesday, Feb. 19, 2020, in Las Vegas.
    Investigations

    Michael Bloomberg gave Biden $19 million. A month later, his company won a major regulatory victory

    Robert Schmad -
    May 6, 2025 12:57 pm
    0
    A student protest about the Israel-Gaza war takes place at the University of California, Berkeley's, Sather Gate, Monday, Oct. 16, 2023.
    Education

    CCP officials and Chinese state entities poured donations into UC Berkeley: Report

    Robert Schmad -
    May 3, 2025 6:00 am
    0
    Bryan Steil (R-WI) chairman of the Committee on House Administration arrives for a hearing about noncitizen voting on Capitol Hill, Thursday, May 16, 2024 in Washington. In recent months, the specter of noncitizens voting in the United States has erupted into a leading rallying cry for Republicans.
    Investigations

    Feeling Blue: How ActBlue, Democrats’ favorite fundraiser, imploded

    Robert Schmad -
    May 1, 2025 2:38 pm
    0
    Beijing-linked groups fund opposition to agriculture bill in move that could boost China
    Investigations

    Beijing-linked groups fund opposition to agriculture bill in move that could boost China

    Robert Schmad -
    May 1, 2025 8:08 am
    0
    The role elite US universities play in training pro-CCP professionals 
    Investigations

    The role elite US universities play in training pro-CCP professionals 

    Robert Schmad -
    April 29, 2025 1:33 pm
    0
    1...8910...24Page 9 of 24
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter